Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry		 vs
history
Cash-to-Debt 0.02
NYSE:CYH's Cash-to-Debt is ranked lower than
88% of the 274 Companies
in the Global Medical Care industry.

( Industry Median: 0.28 vs. NYSE:CYH: 0.02 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:CYH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: 0.15
Current: 0.02
0
0.15
Equity-to-Asset -0.05
NYSE:CYH's Equity-to-Asset is ranked lower than
95% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. NYSE:CYH: -0.05 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:CYH' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.05  Med: 0.16 Max: 0.46
Current: -0.05
-0.05
0.46
Debt-to-Equity -15.60
NYSE:CYH's Debt-to-Equity is ranked lower than
99.99% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 0.64 vs. NYSE:CYH: -15.60 )
Ranked among companies with meaningful Debt-to-Equity only.
NYSE:CYH' s Debt-to-Equity Range Over the Past 10 Years
Min: -18.14  Med: 3.54 Max: 11.49
Current: -15.6
-18.14
11.49
Debt-to-EBITDA -11.04
NYSE:CYH's Debt-to-EBITDA is ranked lower than
99.99% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 2.81 vs. NYSE:CYH: -11.04 )
Ranked among companies with meaningful Debt-to-EBITDA only.
NYSE:CYH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -13.51  Med: 5.56 Max: 42.23
Current: -11.04
-13.51
42.23
Interest Coverage 0.23
NYSE:CYH's Interest Coverage is ranked lower than
99.99% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 6.85 vs. NYSE:CYH: 0.23 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:CYH' s Interest Coverage Range Over the Past 10 Years
Min: 0.23  Med: 1.43 Max: 1.78
Current: 0.23
0.23
1.78
Piotroski F-Score: 2
Altman Z-Score: 0.38
Beneish M-Score: -2.88
WACC vs ROIC
6.05%
1.23%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry		 vs
history
Operating Margin % 1.50
NYSE:CYH's Operating Margin % is ranked lower than
88% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 6.83 vs. NYSE:CYH: 1.50 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:CYH' s Operating Margin % Range Over the Past 10 Years
Min: 1.41  Med: 7.65 Max: 9.07
Current: 1.5
1.41
9.07
Net Margin % -16.16
NYSE:CYH's Net Margin % is ranked lower than
89% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 3.88 vs. NYSE:CYH: -16.16 )
Ranked among companies with meaningful Net Margin % only.
NYSE:CYH' s Net Margin % Range Over the Past 10 Years
Min: -16.16  Med: 1.4 Max: 2.22
Current: -16.16
-16.16
2.22
ROE % -12544.44
NYSE:CYH's ROE % is ranked lower than
99% of the 255 Companies
in the Global Medical Care industry.

( Industry Median: 8.03 vs. NYSE:CYH: -12544.44 )
Ranked among companies with meaningful ROE % only.
NYSE:CYH' s ROE % Range Over the Past 10 Years
Min: -12544.44  Med: 6.84 Max: 13.65
Current: -12544.44
-12544.44
13.65
ROA % -12.25
NYSE:CYH's ROA % is ranked lower than
89% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 3.48 vs. NYSE:CYH: -12.25 )
Ranked among companies with meaningful ROA % only.
NYSE:CYH' s ROA % Range Over the Past 10 Years
Min: -12.48  Med: 1.1 Max: 1.95
Current: -12.25
-12.48
1.95
ROC (Joel Greenblatt) % -23.18
NYSE:CYH's ROC (Joel Greenblatt) % is ranked lower than
89% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 14.91 vs. NYSE:CYH: -23.18 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:CYH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -23.18  Med: 13.88 Max: 16.43
Current: -23.18
-23.18
16.43
3-Year Revenue Growth Rate -6.00
NYSE:CYH's 3-Year Revenue Growth Rate is ranked lower than
85% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. NYSE:CYH: -6.00 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:CYH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -6  Med: 9.5 Max: 47.2
Current: -6
-6
47.2
GuruFocus has detected 4 Warning Signs with Community Health Systems Inc NYSE:CYH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:CYH's 30-Y Financials

Financials (Next Earnings Date: 2018-11-01 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income
» NYSE:CYH's Warning Signs

Warning Signs

Subscribe to see Warning Signs. .

Start your free trial

» Details

Guru Trades
Q3 2017

CYH Guru Trades in Q3 2017

Jeremy Grantham 41,200 sh (New)
Chuck Royce 2,482,295 sh (+10.04%)
Ron Baron 100 sh (unchged)
Jim Simons Sold Out
Barrow, Hanley, Mewhinney & Strauss 444,459 sh (-0.14%)
Joel Greenblatt 641,775 sh (-33.38%)
» More
Q4 2017

CYH Guru Trades in Q4 2017

Paul Tudor Jones 40,210 sh (New)
Steven Cohen 2,223,900 sh (New)
Jeremy Grantham 66,300 sh (+60.92%)
Ron Baron 100 sh (unchged)
Chuck Royce 2,372,795 sh (-4.41%)
Barrow, Hanley, Mewhinney & Strauss 131,807 sh (-70.34%)
Joel Greenblatt 165,286 sh (-74.25%)
» More
Q1 2018

CYH Guru Trades in Q1 2018

Lee Ainslie 248,450 sh (New)
Ron Baron 100 sh (unchged)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
Jeremy Grantham Sold Out
Joel Greenblatt Sold Out
Barrow, Hanley, Mewhinney & Strauss 131,449 sh (-0.27%)
Chuck Royce 1,579,895 sh (-33.42%)
» More
Q2 2018

CYH Guru Trades in Q2 2018

Joel Greenblatt 91,563 sh (New)
Ron Baron 100 sh (unchged)
George Soros 570,000 sh (unchged)
Lee Ainslie Sold Out
Barrow, Hanley, Mewhinney & Strauss Sold Out
Chuck Royce 1,467,395 sh (-7.12%)
» More
» Details

Insider Trades

Financial Reports

Latest Guru Trades with NYSE:CYH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2018-06-30 New Buy$3.32 - $5.09 $ 3.61-15%91,563
Barrow, Hanley, Mewhinney & Strauss 2018-06-30 Sold Out $3.32 - $5.09 $ 3.61-15%0
Barrow, Hanley, Mewhinney & Strauss 2018-03-31 Reduce -0.27%$3.96 - $6.18 $ 3.61-28%131,449
Joel Greenblatt 2018-03-31 Sold Out 0.01%$3.96 - $6.18 $ 3.61-28%0
Joel Greenblatt 2017-12-31 Reduce -74.25%0.05%$3.99 - $7.83 $ 3.61-28%165,286
Barrow, Hanley, Mewhinney & Strauss 2017-12-31 Reduce -70.34%0.01%$3.99 - $7.83 $ 3.61-28%131,807
Joel Greenblatt 2017-09-30 Reduce -33.38%0.04%$6.07 - $9.94 $ 3.61-54%641,775
Barrow, Hanley, Mewhinney & Strauss 2017-09-30 Reduce -0.14%$6.07 - $9.94 $ 3.61-54%444,459
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:LSE:CMBN, LSE:CTH, HKSE:02138, BKK:CMR, SGX:588, HKSE:01526, ASX:GXL, SGX:RF1U, NSE:HCG, LSE:GHG, XSGO:LAS CONDES, HKSE:02120, HKSE:03689, NAS:AMEH, SGX:QC7, OHEL:PIHLIS, HKSE:03869, BOM:540797, XTER:MED, ASX:VRT » details
Traded in other countries:CG5.Germany,
Headquarter Location:USA
Community Health Systems Inc is a operators of general acute care hospitals. The company operates in hospital operations which includes its general acute care hospitals and related healthcare entities.

Community Health Systems is the largest publicly owned hospital operator in the United States. The company owns or leases 123 general acute-care hospitals located in nonurban and urban markets. The company also owns four home health agencies and provides management and consulting services to independent hospitals.

Top Ranked Articles about Community Health Systems Inc

Factors of Influence in 2018, Key Indicators and Opportunity within Community Health, Monotype Imaging, Cardlytics, Sanchez Energy, First Horizon National, and Aradigm — New Research Emphasizes Economic Growth
July 31, 2018
Read more...
Detailed Research: Economic Perspectives on Alphabet, NIKE, Community Health, MTS, First Financial Bankshares, and Polaris Industries — What Drives Growth in Today's Competitive Landscape
July 30, 2018
Read more...
Community Health Systems To Broadcast Second Quarter 2018 Conference Call Live On The Internet
July 18, 2018
Read more...
Community Health Systems To Broadcast First Quarter 2018 Conference Call Live On The Internet
April 17, 2018
Read more...
Factors of Influence in 2018, Key Indicators and Opportunity within McDonald's, Biogen, Freeport-McMoRan, Community Health, Enphase Energy, and Exxon Mobil — New Research Emphasizes Economic Growth
April 16, 2018
Read more...
Community Health Systems To Broadcast Fourth Quarter And Year-End 2017 Conference Call Live On The Internet
February 13, 2018
Read more...
Recent Analysis Shows Hanmi Financial, Shiloh Industries, CommerceHub, Verizon Communications, Community Health, and Humana Market Influences — Renewed Outlook, Key Drivers of Growth
February 5, 2018
Read more...
Report: Developing Opportunities within Twitter, GoPro, Mohawk Industries, Community Health, NetApp, and Ultra Petroleum — Future Expectations, Projections Moving into 2018
November 29, 2017
Read more...
Almost Family, Inc. to Report Third Quarter 2017 Financial Results After Market Close on November 7, 2017
November 4, 2017
Read more...
4 Stocks Retreat on Thursday Tesla, Tenaris, GoPro and Community Health Systems respond to quarterly results
November 2, 2017
Markets were mixed in Thursday trading ahead of President Donald Trump's decision to nominate Jerome Powell to be chairman of the Federal Reserve when Chairwoman Janet Yellen ends her term in February. Read more...

Ratios

vs
industry		 vs
history
PS Ratio 0.03
CYH's PS Ratio is ranked higher than
99% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. CYH: 0.03 )
Ranked among companies with meaningful PS Ratio only.
CYH' s PS Ratio Range Over the Past 10 Years
Min: 0.02  Med: 0.19 Max: 0.47
Current: 0.03
0.02
0.47
Price-to-Operating-Cash-Flow 1.13
CYH's Price-to-Operating-Cash-Flow is ranked higher than
99% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 14.67 vs. CYH: 1.13 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CYH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0.49  Med: 2.06 Max: 5.45
Current: 1.13
0.49
5.45
EV-to-EBIT -7.00
CYH's EV-to-EBIT is ranked lower than
99.99% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 21.68 vs. CYH: -7.00 )
Ranked among companies with meaningful EV-to-EBIT only.
CYH' s EV-to-EBIT Range Over the Past 10 Years
Min: -23.6  Med: 10.3 Max: 30.9
Current: -7
-23.6
30.9
EV-to-EBITDA -11.27
CYH's EV-to-EBITDA is ranked lower than
99.99% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 15.23 vs. CYH: -11.27 )
Ranked among companies with meaningful EV-to-EBITDA only.
CYH' s EV-to-EBITDA Range Over the Past 10 Years
Min: -13.8  Med: 7.3 Max: 646
Current: -11.27
-13.8
646
EV-to-Revenue 1.00
CYH's EV-to-Revenue is ranked higher than
82% of the 271 Companies
in the Global Medical Care industry.

( Industry Median: 2.17 vs. CYH: 1.00 )
Ranked among companies with meaningful EV-to-Revenue only.
CYH' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.8  Med: 1 Max: 2.1
Current: 1
0.8
2.1
Current Ratio 1.79
CYH's Current Ratio is ranked higher than
63% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. CYH: 1.79 )
Ranked among companies with meaningful Current Ratio only.
CYH' s Current Ratio Range Over the Past 10 Years
Min: 1.28  Med: 1.76 Max: 2.34
Current: 1.79
1.28
2.34
Quick Ratio 1.58
CYH's Quick Ratio is ranked higher than
61% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.24 vs. CYH: 1.58 )
Ranked among companies with meaningful Quick Ratio only.
CYH' s Quick Ratio Range Over the Past 10 Years
Min: 1.14  Med: 1.56 Max: 2.14
Current: 1.58
1.14
2.14
Days Inventory 66.01
CYH's Days Inventory is ranked lower than
82% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 17.07 vs. CYH: 66.01 )
Ranked among companies with meaningful Days Inventory only.
CYH' s Days Inventory Range Over the Past 10 Years
Min: 59.18  Med: 65.29 Max: 68.3
Current: 66.01
59.18
68.3
Days Sales Outstanding 62.87
CYH's Days Sales Outstanding is ranked lower than
70% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 39.87 vs. CYH: 62.87 )
Ranked among companies with meaningful Days Sales Outstanding only.
CYH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.58  Med: 57.74 Max: 67.81
Current: 62.87
49.58
67.81
Days Payable 125.82
CYH's Days Payable is ranked higher than
77% of the 176 Companies
in the Global Medical Care industry.

( Industry Median: 40.58 vs. CYH: 125.82 )
Ranked among companies with meaningful Days Payable only.
CYH' s Days Payable Range Over the Past 10 Years
Min: 94.82  Med: 140.58 Max: 175.38
Current: 125.82
94.82
175.38

Buy Back

vs
industry		 vs
history
3-Year Average Share Buyback Ratio 0.60
CYH's 3-Year Average Share Buyback Ratio is ranked higher than
86% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. CYH: 0.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CYH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -21.9  Med: 0.35 Max: 3.8
Current: 0.6
-21.9
3.8

Valuation & Return

vs
industry		 vs
history
Price-to-Median-PS-Value 0.15
CYH's Price-to-Median-PS-Value is ranked higher than
98% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. CYH: 0.15 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CYH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.14  Med: 1.38 Max: 9.98
Current: 0.15
0.14
9.98
Earnings Yield (Greenblatt) % -14.30
CYH's Earnings Yield (Greenblatt) % is ranked lower than
93% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 3.61 vs. CYH: -14.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CYH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -14.4  Med: 7.4 Max: 11.2
Current: -14.3
-14.4
11.2
Forward Rate of Return (Yacktman) % -106.36
CYH's Forward Rate of Return (Yacktman) % is ranked lower than
99% of the 133 Companies
in the Global Medical Care industry.

( Industry Median: 9.10 vs. CYH: -106.36 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CYH' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -106.36  Med: 16.95 Max: 84.6
Current: -106.36
-106.36
84.6

More Statistics

Revenue (TTM) (Mil) $13,975.00
EPS (TTM) $ -20.18
Beta2.32
Volatility56.89%
52-Week Range $2.66 - 7.93
Shares Outstanding (Mil)116.25

Analyst Estimate

Dec18 Dec19 Dec20
Revenue (Mil $) 13,932 13,187 13,382
EBIT (Mil $) 933 954 1,030
EBITDA (Mil $) 1,621 1,597 1,650
EPS ($) -2.39 -0.90 -0.42
EPS without NRI ($) -2.39 -0.90 -0.42
EPS Growth Rate
(Future 3Y To 5Y Estimate)		 N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 22
Positive ROAN
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

» More Articles for NYSE:CYH

Headlines

Articles On GuruFocus.com
Factors of Influence in 2018, Key Indicators and Opportunity within Community Health, Monotype Imagi Jul 31 2018 
Detailed Research: Economic Perspectives on Alphabet, NIKE, Community Health, MTS, First Financial B Jul 30 2018 
Community Health Systems To Broadcast Second Quarter 2018 Conference Call Live On The Internet Jul 18 2018 
Community Health Systems To Broadcast First Quarter 2018 Conference Call Live On The Internet Apr 17 2018 
Factors of Influence in 2018, Key Indicators and Opportunity within McDonald's, Biogen, Freeport-McM Apr 16 2018 
Community Health Systems To Broadcast Fourth Quarter And Year-End 2017 Conference Call Live On The I Feb 13 2018 
Recent Analysis Shows Hanmi Financial, Shiloh Industries, CommerceHub, Verizon Communications, Commu Feb 05 2018 
Report: Developing Opportunities within Twitter, GoPro, Mohawk Industries, Community Health, NetApp, Nov 29 2017 
Almost Family, Inc. to Report Third Quarter 2017 Financial Results After Market Close on November 7 Nov 04 2017 
4 Stocks Retreat on Thursday Nov 02 2017 

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}